Related Experiment Video
Updated: Feb 12, 2026

Use of a Psychophysiological Script-driven Imagery Experiment to Study Trauma-related Dissociation in Borderline Personality Disorder
Published on: March 8, 2018
Comparable prognostic impact of BNP levels among HFpEF, Borderline HFpEF and HFrEF: a report from the CHART-2 Study
Shintaro Kasahara1, Yasuhiko Sakata2, Kotaro Nochioka1
1Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Insights
Plasma B-type natriuretic peptide (BNP) levels effectively stratify long-term mortality risk in heart failure (HF) patients across preserved, borderline, and reduced ejection fraction groups. BNP offers comparable prognostic value regardless of heart failure type.
Area of Science:
- Cardiology
- Biomarkers
- Heart Failure Research
Background:
- Heart failure (HF) encompasses diverse patient groups based on left ventricular ejection fraction (LVEF).
- Accurate long-term risk stratification is crucial for managing HF patients with varying LVEF.
- Plasma B-type natriuretic peptide (BNP) is a recognized biomarker in HF, but its utility across different LVEF categories requires further comparison.
Purpose of the Study:
- To compare the effectiveness of plasma B-type natriuretic peptide (BNP) levels for long-term risk stratification in heart failure patients with preserved (HFpEF), borderline, and reduced (HFrEF) left ventricular ejection fraction (LVEF).
- To determine if BNP's prognostic impact varies across these distinct HF phenotypes within a single cohort.
Main Methods:
- Analysis of 4301 consecutive Stage C/D heart failure patients from the CHART-2 Study.
- Categorization into three groups: HFpEF (LVEF ≥ 50%), borderline HFpEF (LVEF 40-50%), and HFrEF (LVEF ≤ 40%).
- Long-term follow-up (median 6.3 years) assessing all-cause mortality, with analysis of plasma BNP levels and their correlation with mortality risk across groups.
Main Results:
- Median BNP levels progressively increased from HFpEF to borderline HFpEF and HFrEF (85.3, 126, and 208 pg/ml, respectively; P < 0.001).
- The relationship between log2 BNP levels and mortality risk was comparable across all three HF groups.
- Increasing BNP levels (30-99, 100-299, and ≥300 pg/ml) were associated with similarly increasing mortality risks in HFpEF, borderline HFpEF, and HFrEF patients (all P < 0.001).
Conclusions:
- Plasma BNP levels demonstrate a comparable and significant prognostic impact for long-term mortality risk stratification among patients with HFpEF, borderline HFpEF, and HFrEF.
- BNP serves as a valuable and consistent biomarker for risk assessment across the spectrum of left ventricular ejection fraction in heart failure.
- These findings support the use of BNP as a unified tool for risk stratification in diverse heart failure populations.
Abstract:
We aimed to compare the usefulness of plasma levels of B-type natriuretic peptide (BNP) for long-term risk stratification among patients with heart failure (HF) with preserved left ventricular ejection fraction (LVEF) (HFpEF), borderline HFpEF, and HF with reduced LVEF (HFrEF) in the same HF cohort. In the CHART-2 Study (N = 10,219), we categorized 4301 consecutive Stage C/D HF patients (mean age 68.7 years, female 32.4%) into 3 groups: HFpEF (LVEF ≥ 50%, N = 2893), borderline HFpEF (LVEF 40-50%, N = 666), and HFrEF (LVEF ≤ 40%, N = 742). During the median 6.3-year follow-up, all-cause deaths occurred in 887 HFpEF, 330 borderline HFpEF, and 330 HFrEF patients. Although median BNP levels increased from HFpEF, borderline HFpEF to HFrEF (85.3, 126 and 208 pg/ml, respectively, P < 0.001), the relationship between log2 BNP levels and the mortality risk was comparable among the 3 groups. As compared with patients with BNP < 30 pg/ml, those with 30-99, 100-299 and ≥ 300 pg/ml had comparably increasing mortality risk among the 3 groups (hazard ratio 2.5, 4.7 and 7.8 in HFpEF, 2.1, 4.2 and 7.0 in borderline HFpEF, and 3.0, 4.7 and 9.5 in HFrEF, respectively, all P < 0.001). BNP levels have comparable prognostic impact among HFpEF, borderline HFpEF, and HFrEF patients.
Related Concept Videos
Run Charts
The R Chart
R charts are pivotal for pinpointing shifts in process variability. Stability is indicated when all data points remain within the defined upper and lower...
Borderline Personality Disorder
Genetic and Environmental Contributions
Borderline Personality...
Pareto Chart
The Pareto chart is named after the Italian economist Vilfredo Pareto, who described the Pareto...
Interpreting R Charts
An R chart plots the range of subsets of measurements collected from a process. Each point on the chart represents the range—defined as the difference between the maximum and minimum...
Interpreting Run Charts

